主要研究方向為中藥有效成分群發現與質量評價研究,從事中藥有效成分群發現、評價與中藥新藥開發工作。近年來在國內外學術刊物包括Phytomedicine、J Pharmaceut Biomed、Drug Des Dev Ther、Drug Dev Ind Pharm、Nat Prod Res、Fitoterapia和Evid-based Compl Alt等發表論文18篇,其中SCI收錄12篇;第一作者或通訊作者發表SCI論文8篇,個人h-index為15。
聯系方式
Tel:025-83271382;Email:lifeicpu@163.com
8篇代表性論文(*為通訊作者):
(1)Shen J, Yang X, Yang Z, Kou J*, Li F*. Enhancement of absorption and bioavailability of echinacoside by verapamil or clove oil. Drug Des Dev Ther. 2015 (9): 4685-4693.
(2)Min Yang, Yang X, An J, Xiao W, Wang Z, Huang W, Yang Z*, Li F*. Comparative pharmacokinetic profiles of tectorigenin in rat plasma by UPLC-MS/MS after oral administration of Iris tectorum Maxim extract and pure tectoridin. J Pharm Biomed Anal. 2015 (114):34-41.
(3)Li F, Yang X, Yang Y, Li P, Yang Z*, and Zhang C *. Phospholipid complex as an approach for bioavailability enhancement of echinacoside. Drug Dev Ind Pharm. 2015 (17): 1-8.
(4)Li F, Cheng T, Dong X, Li P*, Yang H*. Global analysis of chemical constituents in Shengmai injection using high performance liquid chromatography coupled with tandem mass spectrometry. J Pharm Biomed Anal. 2015. Accepted.
(5)Yang X, Yuan Y, Zhang D, Li F* and Ye W *. Shinjulactone O, a new quassinoid from the root bark of Ailanthus altissima. Nat Prod Res. 2014, 28 (18): 1432-1437.
(6)Li F, Yang X, Yang Y, Guo C, Zhang C, Yang Z, Li P. Antiosteoporotic activity of echinacoside in ovariectomized rats. Phytomedicine, 2013 (20): 549-557.
(7)Li F, Yang Y, Zhu P, Chen W, Qi D, Shi X, Zhang C, Yang Z, Li P. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia.2012 (83): 1443-1450.
(8)Yang X, Li F(co-first author), Yang Y, Shen J, Zou R, Zhu P, Zhang C, Yang Z, Li P. Efficacy and safety of echinacoside in a rat osteopenia. Evid Based Complement Alternat Med. 2013, 2013: 926928.